|
|
|
LH Dividend History & Description — Laboratory Corporation of America Holdings
Laboratory Corporation of America Holdings is a global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make decisions. Co. reports its business in two segments, LabCorp Diagnostics (Dx) and Labcorp Drug Development (DD). Dx is an independent clinical laboratory business. Co. provides a menu of frequently requested primary testing and specialty testing through a network of primary and specialty laboratories across the U.S. DD provides end-to-end drug development, medical device and companion diagnostic development solutions from early-stage research to clinical development and commercial market access. When considering the Laboratory Corporation of America Holdings stock dividend history, we have taken known splits into account, such that the LH dividend history is presented on a split-adjusted ("apples to apples") basis. Laboratory Corporation of America Holdings dividend history is presented both in graphical/chart form, and as a LH dividend history data table along the right-hand column.
Name: |
Laboratory Corporation of America Holdings |
Website: |
www.labcorp.com |
Sector: |
Diagnostics |
Number of ETFs Holding LH: |
99 (see which ones) |
Total Market Value Held by ETFs: |
$2,970,722,093.84 |
Total Market Capitalization: |
$18,128,000,000 |
% of Market Cap. Held by ETFs: |
16.39% |
|
LH Stock Dividend HistoryThe LH dividend history graphic shown above is presented after taking into consideration any known stock split occurrences, in order to present the most directly comparable LH historical dividend comparison possible. Historical dividends, when charted graphically, can reveal the long-term variability and/or growth within the LH dividend history record. Also see the LH stock dividend history data table along the right-hand column below.
|
|
|
|
Buy (3.43 out of 4)
57th percentile
|
|
|